MediciNova Inc (NASDAQ:MNOV)
| 3.02 Data as of 12:18pm ET |  -0.16 / -5.03%Today’s Change | 1.29 Today|||52-Week Range 4.70 | +84.15% Year-to-Date |
Latest MNOV News | Press Releases
No recent news for MediciNova Inc.
Today’s Trading
| Previous close | 3.18 |
| Today’s open | 3.10 |
| Day’s range | 2.98 - 3.10 |
| Volume | 31,402 |
| Average volume (3 months) | 181,884 |
| Market cap | $62.5M |
| Dividend yield | -- |
Data as of 12:18pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | +45.00% |
| Earnings growth (this year) | +18.18% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 33.76 |
| Price/Book | 3.72 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SYNSynthetic Biologics ... | -0.04 | -2.84% |
| RDHLRedhill Biopharma Lt... | +0.85 | +7.99% |
| --Hubei Minkang Pharma... | 0.00 | 0.00% |
| TKMRTekmira Pharmaceutic... | -0.03 | -0.63% |
Data as of 12:12pm ET, 05/23/2013
Financials
| Next reporting date | August 16, 2013 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $802.6K |
| Annual profit (last year) | -$11.0M |
| Net profit margin | -1,365.76% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Yuichi Iwaki, MD, PhD |
Chief Financial & Accounting Officer Michael J. Gennaro, MBA, CPA |
Corporate headquarters San Diego, California |
Forecasts
